TYSONS CORNER, Va., April 1, 2014 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the specialty pharmacy it recently entered into a management agreement with recorded $494,643 in prescription sales for the month of March.
The pharmacy has generated a total of $642,267 in revenue over the last six weeks since ScripsAmerica entered an agreement to manage its operations in exchange for a significant percentage of its revenues. March's revenues give the pharmacy an annual run rate of $5.94 million.
"ScripsAmerica is very pleased to report that our new specialty pharmacy generated very strong revenues in March and we anticipate its monthly prescription sales to experience steady growth. This represents a new and consistent monthly revenue stream that will increase Scrips' shareholder value in addition to our pharmaceutical distribution equity ventures and sales of RapiMed," commented ScripsAmerica's CEO, Bob Schneiderman.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com .
